Martes, 1 de septiembre de 2009

Los estudios MADIT-CRT y PROTECT fueron lo más destacado de la penúltima jornada en el Congreso de la Sociedad Europea de Cardiología. Accede a éstas y el resto de sesiones que se celebraron a lo largo del día.

Presentación	Ponente	Tema
Acquired immune deficiency syndrome in the heart of Africa.	B M Mayosi (Cape Town, ZA)	Epidemiology & prevention
Hypertension: meeting the need in Africa.	D Lemogoum (Brussels, BE)	Epidemiology & prevention
Advances in the medical and surgical treatment of endomyocardial fibrosis.	A O Mocumbi (Maputo, MZ)	Epidemiology & prevention
The role of Pan African Society of Cardiology.	A G B Amoah (Accra., GH)	Epidemiology & prevention
Hypertension and peripheral disease.	D L Clement (Gent, BE)	Hypertension
Heart failure and hotlines.	G Filippatos (Athens, GR)	Heart failure / LV dysfunction
Risk stratification and coronary heart disease.	S Silber (Muenchen, DE)	Epidemiology & prevention
Stroke and imaging.	C Rapezzi (Bologna, IT)	Peripheral circulation/Stroke
Arrhythmia and pacing.	J Brugada Terradellas (Barcelona, ES)	Arrhythmias / Pacing / Resynchronisation
Effects of Valsartan on morbidity and mortality in uncontrolled hypertensive patients with high risk of cardiovascular events (KYOTO Heart Study).	H Matsubara (Kamigyo-ku, JP)	Hypertension
KYOTO Heart Study: Discussant.	F Ruschitzka (Zurich, CH)	Hypertension
Effects of Rolofylline in Patients with Acute Heart Failure Syndrome and Renal Impairment: Findings from the PROTECT- Study.	M Metra (Brescia, IT)	Heart failure / LV dysfunction
PROTECT-Study: Discussant.	M Jessup (Philadelphia, US)	Heart failure / LV dysfunction
A randomized evaluation of irbesartan versus placebo in patients with Atrial Fibrillation (factorial design of ACTIVE Program).	S Yusuf (Hamilton, CA)	Arrhythmias / Pacing / Resynchronisation
ACTIVE Program: Discussant.	J Brugada Terradellas (Barcelona, ES)	Arrhythmias / Pacing / Resynchronisation
European CRT Survey.	N Bogale (Stavanger, NO)	Arrhythmias / Pacing / Resynchronisation
European CRT Survery: Discussant.	J C Daubert (Rennes, FR)	Arrhythmias / Pacing / Resynchronisation
Prevention of Sudden Cardiac Death in Post Myocardial Infarction Patients: Risk Stratification, ICD Therapy Penetration and Related Longterm Outcome: Final Results of the German PreSCD II Registry.	H Voeller (Rudersdorf, DE)	Arrhythmias / Pacing / Resynchronisation
German PreSCD II Registry: Discussant.	P E Vardas (Heraklion, GR)	Arrhythmias / Pacing / Resynchronisation
Multimodality imaging in heart failure.	S R Underwood (London, GB)	Nuclear cardiology, CMR & CT
Multimodality imaging in coronary heart disease.	H J Ukkonen (Turku, FI)	Nuclear cardiology, CMR & CT
Endocarditis is a changing disease: an epidemiological point of view.	B Hoen (Besancon, FR)	Valvular disease
Prevention or prophylaxis? Is antibiotic prophylaxis still necessary?	P Moreillon (Lausanne, CH)	Valvular disease
Prognostic assessment.	I Vilacosta (Madrid, ES)	Valvular disease
Indications and optimal timing for surgery.	P Tornos Mas (Barcelona, ES)	Valvular disease
ESC/ERS pulmonary hypertension Guidelines: Classification.	G Simonneau (Clamart Cedex, FR)	Pulmonary circulation
ESC/ERS pulmonary hypertension Guidelines: Diagnosis.	A Torbicki (Warsaw, PL)	Pulmonary circulation
ESC/ERS pulmonary hypertension Guidelines: Risk stratification and follow-up.	M M Hoeper (Hannover, DE)	Pulmonary circulation
ESC/ERS pulmonary hypertension Guidelines: Treatment.	J S Russell Gibbs (London, GB)	Pulmonary circulation
Predicting cardiovascular disease: does C-reactive protein add anything?	T A Pearson (Rochester, US)	Epidemiology & prevention
Stroke prevention in atrial fibrillation: who should be on more than aspirin?	J W Mant (Cambridge, GB)	Arrhythmias / Pacing / Resynchronisation
What's the quality of cardiovascular care in European primary care?	S Ludt (Heidelberg, DE)	Epidemiology & prevention
Differences in heart failure management: the dimension of the problem.	P Ponikowski (Wroclaw, PL)	Heart failure / LV dysfunction
The challenges in Europe.	A P Maggioni (Florence, IT)	Heart failure / LV dysfunction
The challenges in the United States.	C O'Connor (Durham, US)	Heart failure / LV dysfunction
Moving forward to global strategies.	M Gheorghiade (Chicago, US)	Heart failure / LV dysfunction
Cardiotoxicity of old anticancer agents.	F Quaini (Parma, IT)	Pharmacology and pharmacotherapy
Cardiotoxicity of new anticancer agents.	J Baselga (Barcelona, ES)	Pharmacology and pharmacotherapy
Imaging: the cardiotoxicity of anticancer agents.	D Mele (Ferrara, IT)	Pharmacology and pharmacotherapy
How to prevent the cardiotoxicity of anticancer agents.	T M Suter (Bern, CH)	Pharmacology and pharmacotherapy
Imaging in asymptomatic subject: what in whom?	M Al-Mallah (Detroit, US)	Nuclear cardiology, CMR & CT
Matching techniques to clinical needs: which test for which question?	J J Bax (Leiden, NL)	Nuclear cardiology, CMR & CT
Is imaging adding incremental prognostic power to biomarkers?	R Gibbons (Rochester, US)	Nuclear cardiology, CMR & CT
New clinical perspectives from imaging technologies.	J M Knuuti (Turku, FI)	Nuclear cardiology, CMR & CT
Exercise and mitochondrial biogenesis.	R Ventura-Clapier (Chatenay-Malabry, FR)	Epidemiology & prevention
Differential impact of training regime on cardiac muscle biology.	O J Kemi (Glasgow, GB)	Epidemiology & prevention
Improving outcomes with exercise: fitness or risk factors?	L E M Vanhees (Leuven, BE)	Epidemiology & prevention
Optimising exercise training for global cardiovascular health.	R Hambrecht (Bremen, DE)	Epidemiology & prevention
Mechanisms of arterial ageing.	J R Cockcroft (Cardiff, GB)	Epidemiology & prevention
Morphological and functional changes of the aged arteries.	J Lekakis (Haidari, Athens, GR)	Epidemiology & prevention
Differences between arterial ageing and atherosclerosis.	L Tokgozoglu (Ankara, TR)	Epidemiology & prevention
Renin and the prorenin/renin receptor.	T Unger (Berlin, DE)	Hypertension
Antifibrotic and destiffening drugs.	W J Paulus (Amsterdam, NL)	Hypertension
Renalase.	E Ritz (Heidelberg, DE)	Hypertension
Implantable devices for hypertension.	W T Abraham (Columbus, US)	Hypertension
Subendothelial lipoprotein retention - a novel target to prevent atherosclerosis.	J Boren (Goteborg, SE)	Vascular biology
Genetic determinants of statin response: what really matters?	R E Collins (Oxford, GB)	Vascular biology
Should we be targeting triglycerides?	B G Nordestgaard (Copenhagen, DK)	Vascular biology
Sphingosin-1-phosphate and vascular tone.	B Levkau (Essen, DE)	Vascular biology
Reduction in the risk of heart failure with preventive cardiac resynchronization therapy: MADIT-CRT Trial.	A J Moss (Rochester, US)	Heart failure / LV dysfunction

Cardiología hoy | Blog

Guías clínicas

Agenda SEC

CardioPODCAST

Cursos SEC

Másteres y Posgrados

Formación SEC 2025

CardioTV

Martes, 1 de septiembre de 2009

Actualidad

Revista Española de Cardiología

REC: Interventional Cardiology

REC: CardioClinics

Socios estratégicos